Page last updated: 2024-10-27

fluconazole and Atrial Fibrillation

fluconazole has been researched along with Atrial Fibrillation in 4 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research Excerpts

ExcerptRelevanceReference
"Bleeding safety in relation to use of systemic fluconazole and topical azoles among patients with atrial fibrillation treated with apixaban, rivaroxaban, or dabigatran is insufficiently explored, despite clinical relevance and several reports suggesting associations."8.12Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran. ( Blanche, P; Gislason, GH; Hansen, ML; Holt, A; Jensen, MH; Lamberts, M; McGettigan, P; Nouhravesh, N; Rasmussen, PV; Schjerning, AM; Schou, M; Strange, JE; Torp-Pedersen, C, 2022)
"Bleeding safety in relation to use of systemic fluconazole and topical azoles among patients with atrial fibrillation treated with apixaban, rivaroxaban, or dabigatran is insufficiently explored, despite clinical relevance and several reports suggesting associations."4.12Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran. ( Blanche, P; Gislason, GH; Hansen, ML; Holt, A; Jensen, MH; Lamberts, M; McGettigan, P; Nouhravesh, N; Rasmussen, PV; Schjerning, AM; Schou, M; Strange, JE; Torp-Pedersen, C, 2022)
" When FE is complicated with prosthetic heart valve and/or atrial fibrillation, the coadministration of antifungal agents and warfarin is inevitable."3.96Fungal endocarditis with heart valve replacement and atrial fibrillation posing a treatment challenge: A case report. ( Cao, S; Ding, C; Wang, R; Xia, M; Zhu, X, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Holt, A1
Strange, JE1
Rasmussen, PV1
Blanche, P1
Nouhravesh, N1
Jensen, MH1
Schjerning, AM1
Schou, M1
Torp-Pedersen, C1
Gislason, GH1
Hansen, ML1
McGettigan, P1
Lamberts, M1
Shimoda, T1
Watanabe, A1
Zhu, X1
Cao, S1
Xia, M1
Ding, C1
Wang, R1
Shibata, S1
Kami, M1
Kanda, Y1
Machida, U1
Iwata, H1
Kishi, Y1
Takeshita, A1
Miyakoshi, S1
Ueyama, J1
Morinaga, S1
Mutou, Y1

Other Studies

4 other studies available for fluconazole and Atrial Fibrillation

ArticleYear
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran.
    The American journal of medicine, 2022, Volume: 135, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azoles; Cross-Over Studies; Dabigatran

2022
Apixaban for Atrial Fibrillation and Systemic Fluconazole: Bleeding Risk and Possible Preventative Measures.
    The American journal of medicine, 2022, Volume: 135, Issue:10

    Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Fluconazole; Hemorrhage; Humans; Pyrazole

2022
Fungal endocarditis with heart valve replacement and atrial fibrillation posing a treatment challenge: A case report.
    Medicine, 2020, Nov-25, Volume: 99, Issue:48

    Topics: Antifungal Agents; Atrial Fibrillation; Candida parapsilosis; Candidiasis; Caspofungin; Combined Mod

2020
Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide.
    American journal of hematology, 2001, Volume: 66, Issue:4

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Antibiotic Prophylaxis; Antifungal Agents; Antin

2001